← Leaderboards
Stefanie S. Jeffrey
University Of Utah
$1,387,387
Attributed
$2,249,907
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $553.4K · FY2008–14$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,249,907 · 2
By mechanism
R01$1,725,040 · 1
R21$524,867 · 1
Top collaborators
- Andrea Hope Bild5 shared
Most similar at University Of Utah
Same institution · by research overlap
- L. Eric Huang$3,433,430
- Yijie Geng$1,145,539
- Alberto Bosque$8,280,564
- Andrea Hope Bild$7,326,006
- John Kimble Frazer$670,290
Others in their field
Top investigators on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard A Gibbs · Baylor College Of Medicine$189,765,274
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- James Dennis Neaton · Northwestern University$166,150,536
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary L. Disis · University Of Washington$91,659,868
Research focus
HeterogeneityCancer PatientCancer TherapyMalignant NeoplasmsBaseResponseMolecularTumorDiagnostic Neoplasm StagingComplexDna MethylationAdenovirusesDna Methyltransferase InhibitorData SetChromatinClinical ApplicationClinical TrialsCancer Cell LineBiologicalBiological ModelsCell LineAppearanceAutomobile DrivingAnticancer Research
Grant awards (7)
A Droplet-Based System for Capture, Manipulation, and Biochemical Profiling of Ra$258,437
R21 · FY2014 · CA · contact PI
A Droplet-Based System for Capture, Manipulation, and Biochemical Profiling of Ra$266,430
R21 · FY2013 · CA · contact PI
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$381,030
R01 · FY2011 · GM
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$384,756
R01 · FY2010 · GM
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$168,650
R01 · FY2010 · GM
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$389,056
R01 · FY2009 · GM
Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer$401,548
R01 · FY2008 · GM